Vaughn Bryan T (CIK 2103999) reported 11 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-06). Recent activity: Buy LH (327 shares), Sell LH (93 shares), Sell LH (234 shares), Buy LH (1,584 shares), Sell LH (451 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-06 | LABCORP HOLDINGS INC. (LH) | EVP and President, Diagnostics | Buy | 327 | $0 |
| 2026-07-06 | LABCORP HOLDINGS INC. (LH) | EVP and President, Diagnostics | Sell | 93 | $26,401 |
| 2026-07-06 | LABCORP HOLDINGS INC. (LH) | EVP and President, Diagnostics | Sell | 234 | $66,968 |
| 2026-03-30 | LABCORP HOLDINGS INC. (LH) | EVP, Diagnostics | Buy | 1,584 | $0 |
| 2026-03-30 | LABCORP HOLDINGS INC. (LH) | EVP, Diagnostics | Sell | 451 | $121,039 |
| 2026-02-13 | LABCORP HOLDINGS INC. (LH) | EVP, Diagnostics | Buy | 323 | $0 |
| 2026-02-13 | LABCORP HOLDINGS INC. (LH) | EVP, Diagnostics | Sell | 93 | $26,960 |
| 2026-02-10 | LABCORP HOLDINGS INC. (LH) | EVP, Diagnostics | Buy | 180 | $0 |
| 2026-02-10 | LABCORP HOLDINGS INC. (LH) | EVP, Diagnostics | Sell | 61 | $16,909 |
| 2026-02-10 | LABCORP HOLDINGS INC. (LH) | EVP, Diagnostics | Buy | 178 | $0 |
| 2026-02-10 | LABCORP HOLDINGS INC. (LH) | EVP, Diagnostics | Sell | 61 | $16,715 |
Source: SEC Form 4 filings · as of 2026-07-06